T. Daemen et al., LIPOSOMAL DOXORUBICIN-INDUCED TOXICITY - DEPLETION AND IMPAIRMENT OF PHAGOCYTIC-ACTIVITY OF LIVER MACROPHAGES, International journal of cancer, 61(5), 1995, pp. 716-721
Doxorubicin entrapped within conventional liposomes (200 nm in diamete
r; lip-Dox) has major toxic effects on liver macrophages of the rat fo
r a considerable period of time following i.v. administration, with re
spect to both specific phagocytic capacity and cell numbers. At differ
ent time-points after injection of lip-Dox or free doxorubicin, radiol
abeled, negatively charged, ''empty'' test liposomes were injected. Ph
agocytic capacity was determined by isolating the liver macrophages an
d measuring the amount of macrophage-associated radioactivity. Four su
bfractions of liver macrophages of different cell-size and with intrin
sically different phagocytic capacity were isolated. Twenty-four hours
after injection of lip-Dox, the phagocytic capacity of the larger-siz
ed liver macrophages was strongly decreased. The relatively low intrin
sic phagocytic capacity of the smaller-sized macrophages was only slig
htly impaired. Phagocytic capacity after injection of lip-Dox was near
ly restored to control values after 14 days. Blood clearance of Klebsi
ella pneumoniae bacteria after pre-treatment with lip-Dox was strongly
decreased. Pre-treatment with the free drug and/or placebo liposomes
had no effect on phagocytic and bacterial blood-clearance capacity. A
major depletion of the liver macrophage population was observed, as re
vealed by both macrophage isolation and histology. Only 2 weeks after
injection of lip-Dox, the number of cells had returned to that seen in
control animals. In view of the important host-defense functions of t
he liver macrophages, especially in the control of tumor growth and in
fection, the findings reported here should be taken into consideration
when lip-Dox is to be administered in anti-tumor therapy.